Abstract:Introduction: Shuanghuanglian injection (lyophilized) (SHLI) is commonly used to treat respiratory tract infection. Shenmai injection (SMI) is mainly used to treat cardiovascular diseases. Despite their widespread clinical use, anaphylactoid reactions (ARs) induced by SHLI and SMI have been reported, which have attracted broad attention. However, the impact of ARs on metabolic changes and the underlying mechanisms are still unclear. Methods: ICR mice were used as model animals and were treated with normal saline, C48/80, SHLI and SMI, respectively. The behavior of mice, auricle blue staining and Evans Blue exudation were used as indexes to evaluate the sensitization of SHLI and SMI and determine the optimal sensitization dose. Anaphylactoid mice model was established based on the optimal dose and enzyme-linked immunosorbent assay (ELISA) was used to model verification. Afterwards, plasma samples of administered mice were profiled by LC-MS metabolomics and analyzed to evaluate the changes in metabolites. Results: High doses of both SHLI and SMI can induce severe anaphylactoid reactions while the reaction induced by SMI was weaker. A Partial Least-Squares Discriminant Analysis (PLS-DA) score plot indicated that following administration, significant metabolic changes occurred in mice. 23 distinct metabolites, including deoxycholic acid, histamine, and 5-hydroxytryptophan, were identified in the SHLI groups. 11 distinct metabolites, including androsterone, 17α-hydroxypregnenolone, and 5-hydroxyindoleacetate, were identified in the SMI groups. Meanwhile, different metabolic pathways of SHLI and SMI were predicted by different metabolites. The associated metabolic pathways include steroid hormone biosynthesis, tryptophan metabolism, histidine metabolism, arachidonic acid metabolism, nicotinate and nicotinamide metabolism, and primary bile acid biosynthesis. Conclusion: Study showed that both SHLI and SMI can induce varying degrees of anaphylactoid reactions, a positive correlation between response intensity and dose was observed. Metabolomics showed that SHLI and SMI may promote the simultaneous release of hormones and inflammatory factors by disturbing relevant metabolic pathways, while SMI may also inhibit the release of inflammatory factors in arachidonic acid metabolic pathway, indicating both pro-inflammatory and anti-inflammatory effects. This study will serve as a reference for developing a new approach to evaluate the safety of SHLI and SMI from perspective of susceptible drug varieties. However, ARs mechanism requires further verification.

The Human Mast Cell Line-1 Cell Membrane Chromatography Coupled with HPLC-ESI-MS/MS Method for Screening Potentical Anaphylactic Components from Chuanxinlian Injection.

New Method of Screening Allergenic Components from Shuanghuanglian Injection: with RBL-2H3/CMC Model Online HPLC/MS System

Simultaneous Identification of the Anaphylactoid Components from Traditional Chinese Medicine Injections Using Rat Basophilic Leukemia 2H3 and Laboratory of Allergic Disease 2 Dual-Mixed/cell Membrane Chromatography Model

On-line screening and verification of haptens in Xiangdan injection combining chemical analysis with activity detection

The Inhibition Of Mast Cell Activation Of Radix Paeoniae Alba Extraction Identified By Tcrp Based And Conventional Cell Function Assay Systems

Liquid Chromatography Tandem Mass Spectrometry Based Label-Free Quantification Method for Assessment of Allergen-Induced Anaphylactoid Reactions.

Development of an On-Line Analytical Platform to Screen Haptens in Shuxuening Injection Based on High-Performance Liquid Chromatography Coupled with Ion-Trap Multistage Mass Spectrometry and Human Serum Albumin Fluorescence Detection.

Screening Potential Anaphylactoid Components in Vinpocetine Injection Using a High Expression Mas‐related G‐protein‐coupled Receptor X2 Cell Membrane Chromatography

An integrated strategy for the identification and screening of anti-allergy components from natural products based on calcium fluctuations and cell extraction coupled with HPLC–Q–TOF–MS

Pseudo‐allergic compounds screened from Shengmai injection by using high‐expression Mas‐related G protein‐coupled receptor X2 cell membrane chromatography online coupled with liquid chromatography and mass spectrometry

An On-Line Analytical Approach for Detecting Haptens in Shuang-huang-lian Powder Injection.

Simultaneous Identification of Three Pseudoallergic Components in Danshen Injection by Using High-Expression Mas-related G Protein Coupled Receptor X2 Cell Membrane Chromatography Coupled Online to HPLC-ESI-MS/MS.

Screening anti‐anaphylactoid components in Polygonum cuspidatum via cell membrane chromatography with LC‐MS targeting Mas‐related G protein‐coupled receptor X2

MrgX2-SNAP-tag/cell Membrane Chromatography Model Coupled with Liquid Chromatography-Mass Spectrometry for Anti-Pseudo-allergic Compound Screening in Arnebiae Radix.

Anaphylactic Rare Saponins Separated from Panax notoginseng Saponin and a Proteomic Approach to Their Anaphylactic Mechanism

Improved cell membrane bioaffinity sample pretreatment technique with enhanced stability for screening of potential allergenic components from traditional Chinese medicine injections

A Combined Cell Membrane Chromatography and Online Hplc/Ms Method for Screening Compounds from Radix Caulophylli Acting on the Human Alpha(1a)-Adrenoceptor

MrgX2-targeted ligand screening from Artemisia capillaris Thunb. extract and receptor-ligand interaction analysis based on MrgX2-HALO-tag/CMC

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis

Accurate Quantification of Β-Hexosaminidase Released from Laboratory of Allergic Diseases 2 Cells Via Liquid Chromatography Tandem Mass Spectrometry Method.

Analysis of allergens in tubeimu saponin extracts by using rat basophilic leukemia 2H3 cell-based affinity chromatography coupled to liquid chromatography and mass spectrometry.